Skip to main content

Table 1 Basic descriptive characteristics of patients

From: Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study

Characteristic Number (percentage) of patientsa
Gender  
   Males 14 (54%)
   Females 12 (46%)
Diagnosis  
   Acute lymphoblastic leukemia 4 (17%)
   Acute myeloid leukemia 7 (29%)
   Myeloproliferative syndrome 5 (17%)
   Chronic lymphatic leukemia 2 (8%)
   Chronic myeloid leukemia 1 (4%)
   Myelodysplastic syndrome 4 (13%)
   Non-Hodgkin lymphoma 2 (8%)
   Hodgkin disease 1 (4%)
Age at ATG treatment, years  
   Mean (minimum, maximum) 43 (24, 62)
Number of ATG doses  
   Two 11 (42%)
   Three 12 (46%)
   Four 3 (12%)
Post-ATG body temperature  
   Normal body temperature 20 (77%)
   Body temperature <37.5°C 5 (20%)
   Body temperature >37.5°C 1 (3%)
  1. aValues are presented as number (percentage) of patients, except for those of 'Age at ATG treatment', which are presented as mean (minimum, maximum). ATG, anti-thymocyte globulin.